We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAGP icon
2026
Plains GP Holdings
PAGP
$5.21B
$3.91M ﹤0.01%
206,488
-47,349
-19% -$888K
TS icon
2027
Tenaris
TS
$28.9B
$3.9M ﹤0.01%
172,309
-1,107,910
-87% -$23.8M
CBRL icon
2028
Cracker Barrel
CBRL
$1.26B
$3.9M ﹤0.01%
25,366
+7,831
+45% +$1.23M
GRA
2029
DELISTED
W.R. Grace & Co.
GRA
$3.88M ﹤0.01%
55,473
+3,416
+7% +$229K
ABG icon
2030
Asbury Automotive
ABG
$4.31B
$3.87M ﹤0.01%
34,595
-2,240
-6% -$241K
UMPQ
2031
DELISTED
Umpqua Holdings Corp
UMPQ
$3.86M ﹤0.01%
218,227
+25,633
+13% +$424K
RBC icon
2032
RBC Bearings
RBC
$17.4B
$3.86M ﹤0.01%
24,369
-782
-3% -$126K
YELP icon
2033
Yelp
YELP
$1.45B
$3.84M ﹤0.01%
110,348
+4,589
+4% +$156K
HELE icon
2034
Helen of Troy
HELE
$644M
$3.84M ﹤0.01%
21,360
-1,368
-6% -$219K
TBPH icon
2035
Theravance Biopharma
TBPH
$874M
$3.84M ﹤0.01%
148,141
+60,976
+70% +$1.18M
RGEN icon
2036
Repligen
RGEN
$7.96B
$3.83M ﹤0.01%
41,451
-26,152
-39% -$2.2M
THBR
2037
DELISTED
Thunder Bridge Acquisition II, Ltd. Class A Ordinary Shares
THBR
$3.83M ﹤0.01%
+385,180
New +$3.81M
CADE
2038
DELISTED
Cadence Bank
CADE
$3.83M ﹤0.01%
121,855
+26,519
+28% +$819K
IRT icon
2039
Independence Realty Trust
IRT
$3.92B
$3.83M ﹤0.01%
271,951
-9,509
-3% -$139K
CNMD icon
2040
CONMED
CNMD
$1.39B
$3.83M ﹤0.01%
34,207
+6,700
+24% +$714K
SWCH
2041
DELISTED
Switch, Inc. Class A Common Stock
SWCH
$3.82M ﹤0.01%
257,728
-148,001
-36% -$2.24M
FXE icon
2042
Invesco CurrencyShares Euro Currency Trust
FXE
$346M
$3.81M ﹤0.01%
+35,813
New +$3.76M
CATY icon
2043
Cathay General Bancorp
CATY
$4.22B
$3.8M ﹤0.01%
99,968
+22,580
+29% +$825K
IRBT
2044
CALL
DELISTED
iRobot
IRBT
$3.8M ﹤0.01%
75,000
-243,100
-76% -$12.2M
FFIN icon
2045
First Financial Bankshares
FFIN
$5.04B
$3.79M ﹤0.01%
107,871
-11,384
-10% -$392K
HWC icon
2046
Hancock Whitney
HWC
$6.2B
$3.78M ﹤0.01%
86,193
+392
+0.5% +$15.9K
SXT icon
2047
Sensient Technologies
SXT
$5.26B
$3.77M ﹤0.01%
57,043
+7,370
+15% +$472K
SYNH
2048
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
$3.77M ﹤0.01%
63,371
+3,247
+5% +$175K
IBKR icon
2049
Interactive Brokers
IBKR
$39.2B
$3.77M ﹤0.01%
323,176
+93,072
+40% +$1.09M
R icon
2050
Ryder
R
$9.83B
$3.77M ﹤0.01%
69,320
+28,017
+68% +$1.46M

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.